Neither Moderna nor Pfizer is officially recommended over the other. The CDC states there is no preferential recommendation for any one COVID-19 vaccine when more than one age-appropriate option is available. That said, the two vaccines differ in meaningful ways, from the amount of active ingredient per dose to side effect rates and how long protection lasts. Those differences can help you decide which one makes more sense for you.
How the Two Vaccines Differ in Design
Both Moderna and Pfizer use the same core technology: a small piece of messenger RNA that teaches your cells to recognize the spike protein on the coronavirus. The key difference is dose size. Moderna’s standard adult dose contains more mRNA per shot. For booster doses, Moderna delivers 50 micrograms of mRNA compared to Pfizer’s 30 micrograms. That higher dose appears to drive a stronger initial immune response, but it also plays a role in how each vaccine feels afterward.
Protection Against Hospitalization and Infection
Early in the vaccine rollout, both vaccines performed nearly identically in the most important measure: keeping people out of the hospital. CDC data from the first months of 2021 showed that full vaccination with either product was 94% effective against COVID-19 hospitalization in adults 65 and older. At that stage, sample sizes were too small to detect a meaningful difference between the two brands.
Over time, as new variants emerged, real-world studies began to show a modest edge for Moderna. A CDC study of hospitalized veterans found that Moderna recipients had significantly higher antibody levels than Pfizer recipients across all age groups and all time periods studied. Both vaccines saw antibody levels decline after about four months, but Moderna’s started from a higher baseline.
For the most recent 2024-2025 formulation, the CDC measured effectiveness without separating the two brands. Among adults 18 and older, the updated vaccine was about 33% effective at preventing emergency department or urgent care visits in the first four months. For adults 65 and older, effectiveness against hospitalization was roughly 45%. These numbers reflect the reality that current vaccines are better at reducing severe illness than preventing infection entirely, regardless of brand.
Side Effects Are More Common With Moderna
Moderna consistently produces more noticeable side effects. Data from the European pharmacovigilance database shows the pattern clearly. Among Moderna recipients, the most frequently reported reactions were headache (23.6%), fever (22.5%), fatigue (20.1%), muscle pain (16.1%), and chills (15.5%). Injection site pain was reported by about 10% of recipients.
Pfizer’s side effect profile followed the same pattern but at lower rates: headache (16.9%), fatigue (15.1%), fever (11.6%), and injection site pain (6.5%). So if your main concern is feeling rough for a day or two after vaccination, Pfizer is the gentler option. Most side effects from either vaccine resolve within 48 hours and are signs that your immune system is responding.
How Long Protection Lasts
Moderna’s higher mRNA dose translates into antibody levels that start higher and remain higher as they naturally decline. In the CDC’s study of veterans, antibody levels were significantly greater among Moderna recipients at every time point measured, though both vaccines showed clear declines after 120 days. This is one reason Moderna may offer a slightly longer window of strong protection before a booster is needed, though both vaccines follow the same general trajectory of waning immunity over several months.
Differences for Children
The two vaccines take notably different approaches for young children. For kids aged 6 months through 5 years, Moderna uses a two-dose series at 25 micrograms per shot. Pfizer uses a three-dose series at just 3 micrograms per shot. The practical difference is significant: Moderna requires one fewer trip to the doctor’s office, while Pfizer uses a much smaller dose per injection. Both were approved unanimously by the CDC’s advisory committee in 2022. If convenience matters, Moderna’s shorter schedule is appealing. If you prefer a lower dose per shot for a small child, Pfizer takes that approach.
Which One Should You Choose
The honest answer is that the differences are real but small enough that getting either vaccine matters far more than which one you pick. If you want to maximize immune response and don’t mind a day of feeling under the weather, Moderna’s higher dose and stronger antibody levels give it a slight edge on paper. If you prefer fewer side effects, Pfizer is the milder experience. For young children, the choice often comes down to whether two visits or three fits your family’s schedule better.
In most cases, the vaccine available at your pharmacy today is the right one. Whichever brand you receive, the protection against severe illness and hospitalization is substantial with either product.